Loading…
UTI - Pharma & Healthcare Fund
Disclosed for 41 months, Jan 2014 to Jun 2017. This scheme is no longer reporting.
Portfolio value
₹311 Cr
down ₹14.6 Cr vs Mar 2017
- Stocks held
- 30
- up 1 vs Mar 2017
- Top 10 weight
- 59.6%
- of the portfolio in its ten largest
- Cash & debt
- 2.9%
- cash, money market and debt
- Moves this month
- 1 in · 0 out
- added to 10, trimmed 16
UTI - Pharma & Healthcare Fund is an active equity fund in the Sectoral / Thematic category from UTI Mutual Fund. In April 2017 it disclosed 30 stocks worth ₹311 Cr, down ₹14.6 Cr from Mar 2017. Its largest positions were Sun Pharmaceutical Industries Limited (16.9%), Aurobindo Pharma Limited (7.2%), Cipla Limited (6.9%); the ten largest together made up 59.6% of the portfolio, and Pharmaceuticals & Biotechnology was the biggest sector at 74.8% of its equity. Cash and debt stood at 2.9%. Compared with Mar 2017 the fund entered 1 new stock and exited 0.
Against 227 other Sectoral / Thematic funds
Concentration
83%
Top-10 weight is higher than 83% of peers
Breadth
13%
Holds more stocks than 13% of peers
Cash
41%
Holds more cash than 41% of peers
Holdings in April 2017
Download CSVEvery line the fund disclosed, with the change against Mar 2017. Click a column to sort; click a company to see every fund that owns it.
- Weight
- 16.85%
- Δ weight
- down 0.40 pts
- Value
- ₹52.4 Cr
- Δ value
- down ₹3.8 Cr
- Status
- Trimmed
- Weight
- 7.19%
- Δ weight
- down 0.45 pts
- Value
- ₹22.3 Cr
- Δ value
- down ₹2.5 Cr
- Status
- Trimmed
- Weight
- 6.87%
- Δ weight
- down 1.92 pts
- Value
- ₹21.3 Cr
- Δ value
- down ₹7.2 Cr
- Status
- Trimmed
- Weight
- 5.97%
- Δ weight
- down 1.08 pts
- Value
- ₹18.5 Cr
- Δ value
- down ₹4.4 Cr
- Status
- Trimmed
- Weight
- 5.95%
- Δ weight
- up 1.62 pts
- Value
- ₹18.5 Cr
- Δ value
- up ₹4.4 Cr
- Status
- Added
- Weight
- 3.90%
- Δ weight
- down 1.09 pts
- Value
- ₹12.1 Cr
- Δ value
- down ₹4.1 Cr
- Status
- Trimmed
- Weight
- 3.33%
- Δ weight
- up 1.04 pts
- Value
- ₹10.4 Cr
- Δ value
- up ₹2.9 Cr
- Status
- Added
- Weight
- 3.32%
- Δ weight
- down 0.24 pts
- Value
- ₹10.3 Cr
- Δ value
- down ₹1.3 Cr
- Status
- Trimmed
- Weight
- 3.09%
- Δ weight
- up 0.16 pts
- Value
- ₹9.6 Cr
- Δ value
- up ₹7 L
- Status
- Added
- Weight
- 3.08%
- Δ weight
- up 0.07 pts
- Value
- ₹9.6 Cr
- Δ value
- down ₹23 L
- Status
- Trimmed
- Weight
- 3.06%
- Δ weight
- up 0.06 pts
- Value
- ₹9.5 Cr
- Δ value
- down ₹25 L
- Status
- Trimmed
- Weight
- 3.05%
- Δ weight
- up 0.12 pts
- Value
- ₹9.5 Cr
- Δ value
- down ₹4 L
- Status
- Held
- Weight
- 2.96%
- Δ weight
- up 0.53 pts
- Value
- ₹9.2 Cr
- Δ value
- up ₹1.3 Cr
- Status
- Added
- Cash, TREPS & receivables
- Weight
- 2.88%
- Δ weight
- down 1.39 pts
- Value
- ₹9 Cr
- Δ value
- down ₹5 Cr
- Status
- Trimmed
- Weight
- 2.82%
- Δ weight
- up 0.01 pts
- Value
- ₹8.8 Cr
- Δ value
- down ₹38 L
- Status
- Trimmed
- Weight
- 2.62%
- Δ weight
- up 0.14 pts
- Value
- ₹8.2 Cr
- Δ value
- up ₹6 L
- Status
- Added
- Weight
- 2.49%
- Δ weight
- up 0.12 pts
- Value
- ₹7.7 Cr
- Δ value
- up ₹2 L
- Status
- Held
- Weight
- 2.28%
- Δ weight
- up 0.21 pts
- Value
- ₹7.1 Cr
- Δ value
- up ₹34 L
- Status
- Added
- Weight
- 2.21%
- Δ weight
- up 0.25 pts
- Value
- ₹6.9 Cr
- Δ value
- up ₹48 L
- Status
- Added
- Weight
- 2.13%
- Δ weight
- up 0.08 pts
- Value
- ₹6.6 Cr
- Δ value
- down ₹5 L
- Status
- Trimmed
- Weight
- 2.11%
- Δ weight
- up 0.08 pts
- Value
- ₹6.6 Cr
- Δ value
- down ₹5 L
- Status
- Trimmed
- Weight
- 1.81%
- Δ weight
- up 0.22 pts
- Value
- ₹5.6 Cr
- Δ value
- up ₹45 L
- Status
- Added
- Weight
- 1.62%
- Δ weight
- up 1.31 pts
- Value
- ₹5 Cr
- Δ value
- up ₹4 Cr
- Status
- Added
- Weight
- 1.54%
- Δ weight
- up <0.01 pts
- Value
- ₹4.8 Cr
- Δ value
- down ₹22 L
- Status
- Trimmed
- Weight
- 1.51%
- Δ weight
- down 0.56 pts
- Value
- ₹4.7 Cr
- Δ value
- down ₹2 Cr
- Status
- Trimmed
- Weight
- 1.16%
- Δ weight
- down 0.06 pts
- Value
- ₹3.6 Cr
- Δ value
- down ₹35 L
- Status
- Trimmed
- Weight
- 1.07%
- Δ weight
- up 0.49 pts
- Value
- ₹3.3 Cr
- Δ value
- up ₹1.4 Cr
- Status
- Added
- Weight
- 1.03%
- Δ weight
- down 0.05 pts
- Value
- ₹3.2 Cr
- Δ value
- down ₹32 L
- Status
- Trimmed
- Weight
- 1.01%
- Δ weight
- up 0.33 pts
- Value
- ₹3.1 Cr
- Δ value
- up ₹93 L
- Status
- Added
- Weight
- 0.99%
- Δ weight
- up 0.99 pts
- Value
- ₹3.1 Cr
- Δ value
- up ₹3.1 Cr
- Status
- New
- Weight
- 0.09%
- Δ weight
- down 0.57 pts
- Value
- ₹27 L
- Δ value
- down ₹1.9 Cr
- Status
- Trimmed
What changed, Mar 2017 to Apr 2017
New New positions (1)
- Apollo Hospitals Enterprise Limited1.0% · ₹3.1 Cr
Exited Exited (0)
None.
Added Biggest additions
- Piramal Enterprises Limitedup ₹4.4 Cr (+1.62% pts)
- FDC Limitedup ₹4 Cr (+1.31% pts)
- Pfizer Limitedup ₹2.9 Cr (+1.04% pts)
- Shilpa Medicare Limitedup ₹1.4 Cr (+0.49% pts)
Sectors
Which sectors the fund is moving towards and away from, and where its money sits now. Shares are of the fund’s classified equity holdings, so they add up to 100%.
Where the weight moved
Compared with
Since Mar 2017, the weight rose most in Finance (+1.6 pts) and Healthcare Services (+1.2 pts), and fell most in Pharmaceuticals & Biotechnology (−3.0 pts).
- Finance4.5% → 6.1%+1.6 pts
- Healthcare Services9.7% → 10.9%+1.2 pts
- Pharmaceuticals8.1% → 8.2%+0.2 pts
- Pharmaceuticals & Biotechnology77.7% → 74.8%−3.0 pts
A sector’s weight changes when the fund buys or sells, and also when its shares rise or fall in price, so a change is not by itself a sign of buying or selling.
Main sectors’ weights over time
| Sector | Apr 2014 | Apr 2016 | Oct 2016 | Jan 2017 | Mar 2017 | Apr 2017 |
|---|---|---|---|---|---|---|
| Pharmaceuticals & Biotechnology | 87.2% | 86.7% | 85.1% | 84.6% | 77.7% | 74.8% |
| Healthcare Services | — | 5.1% | 6.2% | 6.3% | 9.7% | 10.9% |
| Pharmaceuticals | 11.8% | 4.7% | 4.6% | 5.0% | 8.1% | 8.2% |
| Finance | 1.0% | 3.6% | 4.0% | 4.1% | 4.5% | 6.1% |
Allocation in Apr 2017change vs Mar 2017
- Pharmaceuticals & Biotechnology (19)74.8%▼ 3.0 pts
- Healthcare Services (6)10.9%▲ 1.2 pts
- Pharmaceuticals (4)8.2%▲ 0.2 pts
Cash and debt
The share of the portfolio not in shares: cash and net receivables, money-market instruments and bonds, as disclosed each month. Cash can dip below zero when payables, often on derivative positions, exceed it. A change here describes what the fund did; it is not a signal.
Cash & debt, Apr 2017
2.9%
▼ 1.4 pts vs Mar 2017
- Cash alone
- 2.9%
- cash and net receivables
- A year earlier
- 7.6%
- Apr 2016 · now ▼ 4.7 pts
- Last 12 months
- 0.7% – 6.9%
- lowest to highest · record 12.6% in Nov 2015
History
Disclosed portfolio value by month, with the stocks the fund entered and exited against its previous disclosure. Every month is a link to that portfolio.